Amylyx launches expanded access program for post-bariatric hypoglycemia drug

Go back to Amylyx launches expanded access program for post-bariatric hypoglycemia drug
(NASDAQ: AMLX) Delayed: 16.27 +0.60 (3.83%)
Previous Close $15.67    52 Week High
Open $15.91    52 Week Low
Day High $16.32    P/E N/A 
Day Low $15.73    EPS
Volume 991,687